GLP-1 Bingo Card: 25 Internet Moments You've Definitely Seen

This GLP-1 bingo card is a joke with a purpose. It's a printable grid of 25 internet tropes you've almost certainly seen in GLP-1 posts, comments and ads. This piece is lighthearted opinion, not data: we're not claiming how often any square shows up. Under the card you'll find the real fact behind the squares, so every "BINGO!" comes with a tiny upgrade to your skepticism.

The golden rule: you mark tropes, never people. Someone sharing their side effects or their journey isn't a square. A gold badge that says "FDA Registered" absolutely is.

How to play GLP-1 internet bingo

1. Print or screenshot the card below.
2. Open your feed, your group chat or the comments under any GLP-1 headline.
3. Mark a square when you spot the trope in the wild.
4. Five in a row (across, down or diagonal) wins. The center square is free, because someone has definitely already called a different drug "Ozempic" today.
5. Blackout means you've been scrolling too long. Close the app and go refill your water bottle.

The printable GLP-1 bingo card

B	I	N	G	O
"FDA Registered!" badge	Before-and-after with no dates	"My cousin's pharmacist said…"	20% risk drop, no baseline	"Research use only" vial with a dosing chart
Discount code + "#collab"	"Nature's Ozempic" supplement	Screenshot of a "study," no link	"Everyone loses 15%"	Comments section turns into a clinical trial
"Ozempic face" debate in the replies	Recycled 2023 headline	FREE: Every GLP-1 called "Ozempic"	"It's cheating" hot take	"Doctors don't want you to know"
"Microdosing" explained by someone with a ring light	"Same as Wegovy, but cheaper!"	A mouse study framed as human news	"No prescription needed"	Someone asks what to eat at a buffet
"Just eat less" reply	Weight graph with no y-axis	"I stopped and gained it ALL back" vs "I stopped and gained NOTHING" fight	"Hundreds of reports!" as proof	A brand-new drug "available now" that isn't approved

Text version for screen readers: the 25 squares, row by row, are: FDA Registered badge; before-and-after with no dates; my cousin's pharmacist said; 20% risk drop with no baseline; research-use-only vial with dosing chart. Discount code with #collab; nature's Ozempic supplement; screenshot of a study with no link; everyone loses 15%; comments become a clinical trial. Ozempic face debate; recycled 2023 headline; FREE: every GLP-1 called Ozempic; it's cheating hot take; doctors don't want you to know. Microdosing explained with a ring light; same as Wegovy but cheaper; mouse study framed as human news; no prescription needed; someone asks what to eat at a buffet. Just eat less; weight graph with no y-axis; stopped and gained it all vs gained nothing fight; hundreds of reports as proof; brand-new drug available now that isn't approved.

The cheat sheet: the real fact behind the squares

You don't need these to win, but they make you the most useful person in the comments.

"FDA Registered!" badge. Federal rules say registering a facility or listing a drug does not mean FDA approved it. Implying approval from registration counts as misbranding. Our misinformation quiz has more badge traps.

FREE square: every GLP-1 called "Ozempic." Ozempic is semaglutide for adults with type 2 diabetes. The weight-management semaglutide brand is Wegovy, and tirzepatide is Mounjaro or Zepbound. As of 2026 there are even Ozempic tablets. Nicknames are fine at brunch, less fine in medical advice.

"Research use only" vial with a dosing chart. FDA has warned companies selling semaglutide, tirzepatide and retatrutide labeled "for research purposes" but marketed to consumers with dosing instructions. The agency says their quality is unknown.

"Same as Wegovy, but cheaper!" Compounded drugs aren't FDA-approved, and FDA says salt forms like semaglutide sodium have no lawful basis for compounding. "Same as" is doing a lot of work in that sentence.

Discount code + "#collab." The FTC says vague tags like "collab" or "ambassador" alone aren't clear disclosures. "Ad" or "sponsored," placed where you can't miss it, is the standard.

"Nature's Ozempic" supplement. FDA doesn't approve supplements before they're sold, and a product marketed to treat a disease is legally a drug.

20% risk drop, no baseline. The famous SELECT result was a 20% relative reduction: 6.5% vs 8.0% had a major heart event over about 40 months. Same truth, very different vibe. More in relative vs absolute risk.

"Everyone loses 15%." On the Wegovy label, the trial average was −14.9%, and 47.9% of people reached 15% or more. An average isn't a guarantee.

"Hundreds of reports!" as proof. FDA says a report to its adverse event system doesn't establish that the drug caused the event.

Recycled 2023 headline. Classic example: in January 2026 FDA asked for the suicidal-ideation warning to be removed from the Saxenda, Wegovy and Zepbound labels after reviewing 91 trials. Check the date before you panic.

"I stopped and gained it ALL back" vs "gained NOTHING." Both are one person's story. In the STEP 1 extension, the average was about two-thirds regained within a year of stopping, with wide individual variation.

Before-and-after with no dates. No timeline, no dose, no context. See why before-and-after stories don't tell the whole story.

A brand-new drug "available now" that isn't approved. Retatrutide is still investigational. If someone is selling it to you, they're selling something outside the approved system.

House rules for keeping it funny

Bingo works because it laughs at patterns: overconfidence, recycled headlines, badges that mean nothing. It stops being funny when it targets a person. So:

• Don't screenshot real people's posts to "prove" a square. Describe the trope instead.
• Side effects aren't tropes. Someone saying they feel awful deserves a kind reply, not a dabber.
• Bodies are never squares. No square on this card is about how anyone looks.
• Correct gently. If you drop a fact from the cheat sheet in the comments, link the source and skip the dunk.

Want the version without the comment-section chaos? The guide to enjoying GLP-1 stories without comparison is the calmer cousin of this card.

Make your own card

Swap in squares from your corner of the internet. A few ideas to get you started: "a 'what I eat in a day' with no portions," "the influencer who 'can't say the brand,'" and "someone discovers protein." Keep the rules: patterns, not people. Facts, not dunks.

If you're on treatment yourself, the best antidote to internet noise is your own record. A note of your dose, your weight trend and how you actually feel beats any viral claim. GLPily keeps those in one place, which makes the comments section a lot easier to scroll past.

Common questions

Is this bingo card making fun of people who take GLP-1s?

No. It makes fun of misleading content: badges, spin and recycled headlines. The house rules ban squares about bodies, side effects or real people.

Can I share or print the card?

Yes, that's what it's for. Use the text version if you're sharing with someone who uses a screen reader.

Where do I check whether a GLP-1 claim is true?

Start with the FDA label on DailyMed, FDA safety communications, or the original study on PubMed. Our social media red flags guide walks through it.